GIM
AGN

Greylin Investment Management’s Allergan plc AGN Stock Holding History

Greylin Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,150
Closed -$236K – 81
2017
Q3 		$236K Buy
+1,150
New +$267K 0.05% 70

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Greylin Investment Management's AGN Position: Q4 2017 in Review

Greylin Investment Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,150 shares — an estimated $236K sold.

Greylin Investment Management first reported a position in AGN in Q3 2017 and held it in 1 quarter. The position peaked at $236K in Q3 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Greylin Investment Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Greylin Investment Management sold 1,150 Allergan plc shares in Q4 2017, an estimated $236K.
  • Greylin Investment Management first reported a position in Allergan plc in Q3 2017 and held it in 1 quarter.
  • Greylin Investment Management's Allergan plc position peaked at $236K in Q3 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Greylin Investment Management's 13F filing for Q4 2017, filed 16 Jan 2018.